TScan-II: A genome-scale platform for the de novo identification of CD4+ T cell epitopes
Cell · 2023
DOI: 10.1016/j.cell.2023.10.024 ↗Kurz gefasst
Kommentar in der Zeitschrift Cell, 2023. Verfasst von Mohammad H Dezfulian und 18 weiteren Autor:innen. Beteiligte Einrichtung: Division of Genetics, Department of Medicine, Howard Hughes Medical Institute, Brigham and Women's Hospital, Boston, MA, USA; Department of Genetics,…. Hauptthemen laut MEDLINE: CD4-Positive T-Lymphocytes, Epitopes, T-Lymphocyte. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Intramural NIH HHS, NHGRI NIH HHS.
Abstract (Originalsprache)
CD4+ T cells play fundamental roles in orchestrating immune responses and tissue homeostasis. However, our inability to associate peptide human leukocyte antigen class-II (HLA-II) complexes with their cognate T cell receptors (TCRs) in an unbiased manner has hampered our understanding of CD4+ T cell function and role in pathologies. Here, we introduce TScan-II, a highly sensitive genome-scale CD4+ antigen discovery platform. This platform seamlessly integrates the endogenous HLA-II antigen-processing machinery in synthetic antigen-presenting cells and TCR signaling in T cells, enabling the simultaneous screening of multiple HLAs and TCRs. Leveraging genome-scale human, virome, and epitope mutagenesis libraries, TScan-II facilitates de novo antigen discovery and deep exploration of TCR specificity. We demonstrate TScan-II's potential for basic and translational research by identifying a non-canonical antigen for a cancer-reactive CD4+ T cell clone. Additionally, we identified two antigens for clonally expanded CD4+ T cells in Sjögren's disease, which bind distinct HLAs and are expressed in HLA-II-positive ductal cells within affected salivary glands.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Genetics, Department of Medicine, Howard Hughes Medical Institute, Brigham and Women's Hospital, Boston, MA, USA; Department of Genetics, Harvard Medical School, Boston, MA, USA.
- Adeno-Associated Virus Biology Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.
- Department of Genetics, Harvard Medical School, Boston, MA, USA; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA; Department of Biomedical Informatics, Harvard Medical School, Bo…
- Department of Medicine, Harvard Medical School, Boston, MA, USA.
- Genes and Human Disease Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
- Salivary Disorders Unit, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.
Förderung
- NCI NIH HHS
- Intramural NIH HHS
- NHGRI NIH HHS
- NIAID NIH HHS
- NIAMS NIH HHS
Zitieren
APA
Dezfulian, M. H., Kula, T., Pranzatelli, T., Kamitaki, N., Meng, Q., Khatri, B., Perez, P., Xu, Q., Chang, A., Kohlgruber, A. C., Leng, Y., Jupudi, A. A., Joachims, M. L., Chiorini, J. A., Lessard, C. J., Farris, A. D., Muthuswamy, S. K., Warner, B. M., & Elledge, S. J. (2023). TScan-II: A genome-scale platform for the de novo identification of CD4+ T cell epitopes. Cell. https://doi.org/10.1016/j.cell.2023.10.024
Vancouver
Dezfulian MH, Kula T, Pranzatelli T, Kamitaki N, Meng Q, Khatri B, et al. TScan-II: A genome-scale platform for the de novo identification of CD4+ T cell epitopes. Cell. 2023. doi:10.1016/j.cell.2023.10.024
BibTeX
@article{Dezfulian2023,
author = {Dezfulian, Mohammad H and Kula, Tomasz and Pranzatelli, Thomas and Kamitaki, Nolan and Meng, Qingda and Khatri, Bhuwan and Perez, Paola and Xu, Qikai and Chang, Aiquan and Kohlgruber, Ayano C and Leng, Yumei and Jupudi, Ananth Aditya and Joachims, Michelle L and Chiorini, John A and Lessard, Christopher J and Farris, A Darise and Muthuswamy, Senthil K and Warner, Blake M and Elledge, Stephen J},
title = {TScan-II: A genome-scale platform for the de novo identification of CD4+ T cell epitopes},
journal = {Cell},
year = {2023},
doi = {10.1016/j.cell.2023.10.024}
}
EUVIMED